Group 1 - The company plans to issue shares to acquire 99.42% equity of Shandong Hongjitang Pharmaceutical Group Co., Ltd. from 38 counterparties, including Linuo Investment Holding Group Co., Ltd. and Linuo Group Co., Ltd. [1] - The company intends to raise supporting funds by issuing shares to no more than 35 qualified specific objects as part of the transaction [1] - The announcement includes a revised draft of the "Report on Issuing Shares to Purchase Assets and Raising Supporting Funds and Related Transactions" [1] Group 2 - The revised report updates the stock issuance price and quantity for the asset purchase, as well as the raised supporting funds [2] - The decision-making process and approval status of the transaction have been updated in the report [2] - The financial status and profitability analysis of the target company have been improved and updated in the management discussion and analysis section [2]

Group 1 - The company plans to acquire 100% equity of Sichuan Yichong Technology Co., Ltd. through a combination of issuing shares and cash payment, while also raising supporting funds [1][2] - The board of directors has approved several related proposals regarding the transaction, including the draft report for the issuance of shares and cash payment [1][2] - The company has made revisions to the draft report, updating the decision-making procedures and approval status related to the transaction [2][3] Group 2 - The revised draft report includes additional disclosures regarding the classification principles of the target company's business asset groups [3] - New disclosures confirm that the transaction complies with relevant regulations, including the restructuring management measures and stock exchange rules [3] - Financial analysis of the target company's asset groups has been added to the management discussion and analysis section of the report [3]

德尔股份（300473）公告，公司拟向上海德迩实业集团有限公司等交易对方以发行股份等方式购买其持 有的爱卓智能科技(上海)有限公司100%股权，并拟向不超过35名特定投资者发行股份募集配套资金。公 司于2025年6月18日收到深圳证券交易所出具的《关于受理阜新德尔汽车部件股份有限公司发行股份购 买资产并募集配套资金申请文件的通知》。深交所根据相关规定对公司报送的申请文件进行了核对，认 为申请文件齐备，决定予以受理。本次交易尚需通过深交所审核并取得中国证监会同意注册的批复，最 终能否通过审核、取得注册，以及最终通过审核、取得注册的时间仍存在不确定性。 ...

Core Viewpoint - Anhui Guofeng New Materials Co., Ltd. plans to acquire a total of 100% equity in Taihu Jinzhan Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds from specific investors [1][2] Group 1 - The company intends to purchase shares from 10 counterparties, including Shike Wei, and will issue shares to no more than 35 qualified investors to raise supporting funds [1] - The transaction is subject to approval from the Shenzhen Stock Exchange and registration with the China Securities Regulatory Commission, indicating potential uncertainties regarding the approval process and timeline [2] - The company commits to adhering to relevant laws and regulations for timely information disclosure regarding the transaction [2]

Overview - Bohai Automotive System Co., Ltd. plans to issue shares and pay cash to acquire assets and raise supporting funds through a related party transaction [1][2][3] - The transaction involves purchasing 51% equity in Beijing Beiqi Moulding Technology Co., Ltd., 51% equity in Langfang Andao Tuo Seating Co., Ltd., 100% equity in Yingnafa Intelligent Technology (Beijing) Co., Ltd., and 50% equity in Langfang Laini Wiring System Co., Ltd. from Hainachuan [7][10] Transaction Details - The company intends to raise supporting funds from no more than 35 specific qualified investors through an inquiry-based issuance of shares [2][3] - The total amount of supporting funds raised will not exceed 100% of the transaction price for the asset acquisition [12][13] - The specific transaction price will be determined based on the evaluation results from a legally compliant evaluation agency [10][17] Impact on Business - The acquisition will expand the company's product line to include automotive exterior parts, seating structures, automotive electronics, and wiring harnesses, enhancing its core competitiveness [16][17] - The transaction is expected to significantly increase the company's total assets, net assets, operating income, and net profit, optimizing its financial condition and enhancing profitability [17][18] Approval Process - The transaction requires approval from the company's board of directors, shareholders' meeting, and regulatory bodies including the China Securities Regulatory Commission (CSRC) [18][19] - The company has received preliminary consent from its controlling shareholders, Hainachuan and Beijing Automotive Group [19][20] Investor Protection Measures - The company will strictly adhere to information disclosure obligations and legal procedures to protect the rights of investors, especially minority shareholders [19][20] - A network voting platform will be provided for shareholders to participate in the decision-making process regarding the transaction [19][20]

证券代码：300757 证券简称：罗博特科 公告编号：2025-045 序号 发行对象名称 发行股数（股） 台州城投沣收一号股权投资合伙企业（有限合 伙） 青岛鹿秀投资管理有限公司-鹿秀长颈鹿 6 号私 募证券投资基金 罗博特科智能科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 罗博特科智能科技股份有限公司（以下简称"公司"或"罗博特科"）拟以 发行股份及支付现金方式购买建广广智（成都）股权投资中心（有限合伙）、苏 州工业园区产业投资基金（有限合伙）、南京永鑫融合创业投资合伙企业（有限 合伙）、上海超越摩尔股权投资基金合伙企业（有限合伙）、尚融宝盈（宁波） 投资中心（有限合伙）、常州朴铧投资合伙企业（有限合伙）、南通能达新兴产 业母基金合伙企业（有限合伙）持有的苏州斐控泰克技术有限公司合计 81.18% 的股权；拟以支付现金方式购买境外交易对方 ELAS Technologies Investment GmbH 持有 ficonTEC Service GmbH 和 ficonTEC Automation GmbH 各 6.97%股 权。同时向 ...

Core Viewpoint - The company plans to acquire 63.2134% equity of Shanghai Ouyi Biomedical Technology Co., Ltd. through a combination of issuing shares and cash payment, while also raising supporting funds [1] Group 1: Transaction Overview - The company intends to purchase assets and raise supporting funds, which involves a significant equity acquisition [1] - The transaction is subject to regulatory scrutiny, as indicated by the inquiry letter received from the Shanghai Stock Exchange [2] Group 2: Amendments and Updates - The company has revised its transaction report to address the requirements outlined in the inquiry letter and updated legal regulations [3] - Key updates include adjustments to the transaction plan, analysis of the impact on the company's equity structure and earnings per share, and additional agreements related to the transaction [3][4] Group 3: Risk Factors - The report highlights risks associated with the concentration of suppliers for production equipment and potential limitations in the procurement of related equipment and reagents [5]

Core Viewpoint - The company, United Optoelectronics, plans to acquire 100% of Dongguan Changyi Optoelectronics through a share issuance and raise matching funds from specific investors, with the stock resuming trading today [1][2]. Group 1: Transaction Details - The share issuance will involve 12 specific investors, with a price set at 16.18 yuan per share, which is at least 80% of the average trading price over the last 20 trading days [2]. - The total amount of matching funds raised will not exceed 100% of the asset purchase price, and the number of shares issued will not exceed 30% of the company's total share capital prior to the issuance [2][3]. - The funds raised will be used for tax payments, intermediary fees, project construction, and to supplement working capital or repay debts, with a maximum of 25% of the transaction price or 50% of the total raised funds allocated for working capital or debt repayment [3]. Group 2: Financial Performance of Target Company - The financial performance of Changyi Optoelectronics shows revenues of 244.17 million yuan, 559.73 million yuan, and 132.85 million yuan for the years 2023 to Q1 2025, with net profits of -50.93 million yuan, 6.10 million yuan, and 7.18 million yuan respectively [5]. Group 3: Control and Governance - Prior to the transaction, there is no existing relationship between the trading parties and the company. However, a voting rights delegation agreement has been signed, indicating a potential future alignment of interests [4]. - The actual controller of the company has not changed due to this transaction, and it does not constitute a major asset restructuring as per regulatory guidelines [5].

中成股份（000151）公告，公司正在筹划发行股份购买中国技术进出口集团有限公司持有的中技江苏清 洁能源有限公司100%股权并募集配套资金。2025年5月27日，公司召开第九届董事会第二十二次会议， 审议通过了关于中成进出口股份有限公司发行股份购买资产并募集配套资金暨关联交易方案的议案。因 本次交易构成关联交易，关联董事已回避表决。具体内容详见公司于同日披露的相关公告。鉴于本次交 易的相关审计、评估等工作尚未完成，公司董事会决定暂不召开股东大会审议本次交易有关事项。待本 次交易涉及的审计、评估等事项完成后，公司将再次召开董事会，对本次交易相关事项作出决议，披露 相关信息，并依照法定程序发布召开股东大会的通知。 ...

Core Viewpoint - The company is planning to issue shares to acquire assets and raise supporting funds, with the transaction not expected to constitute a major asset restructuring or a reverse listing [1]. Group 1 - The company's stock will be suspended from trading starting May 20, 2025, to protect investor interests and avoid significant impacts on stock trading due to uncertainties surrounding the transaction [1][2]. - The company expects to disclose the transaction plan within no more than 10 trading days, specifically by June 4, 2025, in accordance with relevant disclosure requirements [2]. - The company is actively conducting negotiations and due diligence related to the transaction, which is progressing in an orderly manner [2]. Group 2 - During the suspension period, the company will continue to advance all related work and fulfill its information disclosure obligations based on the progress of the transaction [2]. - The company will submit and disclose relevant documents to the Shenzhen Stock Exchange and apply for stock resumption once the related matters are confirmed [2]. - All information will be based on disclosures made in designated information disclosure media, and investors are advised to pay attention to subsequent announcements [2].